These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
406 related items for PubMed ID: 16764763
1. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma]. Liu WJ, Wang L, Wang JP, Li JQ, Zhang CQ, Zheng L, Yuan YF. Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763 [Abstract] [Full Text] [Related]
2. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma. Li B, Liu W, Wang L, Li M, Wang J, Huang L, Huang P, Yuan Y. Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070 [Abstract] [Full Text] [Related]
3. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma. Zhang C, Li Z, Cheng Y, Jia F, Li R, Wu M, Li K, Wei L. Clin Cancer Res; 2007 Feb 01; 13(3):944-52. PubMed ID: 17289889 [Abstract] [Full Text] [Related]
4. Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma. Cheng Y, Zhang C, Zhao J, Wang C, Xu Y, Han Z, Jiang G, Guo X, Li R, Bu X, Wu M, Wei L. Exp Mol Pathol; 2010 Feb 01; 88(1):112-7. PubMed ID: 19879258 [Abstract] [Full Text] [Related]
5. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Chang MS, Uozaki H, Chong JM, Ushiku T, Sakuma K, Ishikawa S, Hino R, Barua RR, Iwasaki Y, Arai K, Fujii H, Nagai H, Fukayama M. Clin Cancer Res; 2006 May 15; 12(10):2995-3002. PubMed ID: 16707594 [Abstract] [Full Text] [Related]
6. Opioid-binding protein/cell adhesion molecule-like (OPCML) gene and promoter methylation status in women with ovarian cancer. Czekierdowski A, Czekierdowska S, Szymanski M, Wielgos M, Kaminski P, Kotarski J. Neuro Endocrinol Lett; 2006 Oct 15; 27(5):609-13. PubMed ID: 17159813 [Abstract] [Full Text] [Related]
7. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma]. Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z. Zhonghua Zhong Liu Za Zhi; 2008 Nov 15; 30(11):831-6. PubMed ID: 19173828 [Abstract] [Full Text] [Related]
9. Promoter methylation status of multiple genes in uveal melanoma. Merhavi E, Cohen Y, Avraham BC, Frenkel S, Chowers I, Pe'er J, Goldenberg-Cohen N. Invest Ophthalmol Vis Sci; 2007 Oct 15; 48(10):4403-6. PubMed ID: 17898258 [Abstract] [Full Text] [Related]
10. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma. Ko E, Kim Y, Kim SJ, Joh JW, Song S, Park CK, Park J, Kim DH. Cancer Epidemiol Biomarkers Prev; 2008 Sep 15; 17(9):2260-7. PubMed ID: 18723830 [Abstract] [Full Text] [Related]
11. [Deletion of OPCML gene and promoter methylation in ovarian epithelial carcinoma]. Zhang J, Ye F, Chen HZ, Ye DF, Lu WG, Xie X. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr 15; 28(2):173-7. PubMed ID: 16733898 [Abstract] [Full Text] [Related]
13. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma. Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y. Clin Cancer Res; 2008 Nov 15; 14(22):7405-12. PubMed ID: 19010857 [Abstract] [Full Text] [Related]
14. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus. Kusano M, Toyota M, Suzuki H, Akino K, Aoki F, Fujita M, Hosokawa M, Shinomura Y, Imai K, Tokino T. Cancer; 2006 Apr 01; 106(7):1467-79. PubMed ID: 16518809 [Abstract] [Full Text] [Related]
15. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM. Mol Carcinog; 2002 Oct 01; 35(2):85-92. PubMed ID: 12325038 [Abstract] [Full Text] [Related]
16. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K. Oncogene; 2000 Nov 02; 19(46):5298-302. PubMed ID: 11077447 [Abstract] [Full Text] [Related]
17. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas. Zhong S, Yeo W, Tang MW, Wong N, Lai PB, Johnson PJ. Clin Cancer Res; 2003 Aug 15; 9(9):3376-82. PubMed ID: 12960125 [Abstract] [Full Text] [Related]
18. Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis. Yu J, Zhang HY, Ma ZZ, Lu W, Wang YF, Zhu JD. Cell Res; 2003 Oct 15; 13(5):319-33. PubMed ID: 14672555 [Abstract] [Full Text] [Related]
19. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Prosper F, Heiniger A, Torres A. J Clin Oncol; 2005 Oct 01; 23(28):7043-9. PubMed ID: 16192589 [Abstract] [Full Text] [Related]
20. [Relationship between CpG island methylator phenotype and genetic instability in sporadic colorectal cancer]. Cai GX, Xu Y, Cai SJ, Shi YQ, Lian P, Peng JJ, Guan ZQ, Du X. Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Nov 01; 10(6):555-60. PubMed ID: 18000779 [Abstract] [Full Text] [Related] Page: [Next] [New Search]